Opinion|Videos|February 7, 2025
Multidisciplinary Approaches to Managing AEs with Bispecifics
Dr Mohan engages with Nurse Goff, Dr Mann, and Nurse Brigle to explore effective multidisciplinary approaches for managing adverse events (AEs) associated with bispecific therapies and compares the AE profiles of talquetamab, teclistamab, and elranatamab, highlighting unique challenges and benefits.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What multidisciplinary approaches have you found most effective in managing the diverse range of AEs associated with bispecific therapies?
- Based on your experience, how do the AE profiles of talquetamab compare with those of other bispecific therapies like teclistamab or elranatamab?
- Are there any unique challenges or benefits you’ve observed?
Advertisement
Related to this article
Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Beth Sandy, CRNP, of Penn Medicine explains how oncology nurses and pharmacists collaborate to manage financial toxicity and secure oral therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Approves Lutetium Lu 177 Dotatate for GEP-NET Care
2
Nurse-Led Support Reduces Death Anxiety in Breast Cancer Care
3
Psycho-Oncology Care: Dr. Erik Bengtsen on Psilocybin & Patient Distress
4
Palliative and Psycho-Oncology Care: Dr. Ramy Sedhom on Patient Distress Signs
5